Billions of employer dollars are flowing into global fertility and family-building care. Almost no one is watching where they go.
The global surrogacy market alone is projected to reach $201.8 billion by 2034. Cross-border fertility care is accelerating as employees travel internationally for IVF, egg freezing, donor services, and gestational surrogacy, often into countries with limited regulatory oversight and no centralized pricing transparency.
Today, Carrot, the leading global fertility and family-building platform, announced its AI-powered Global Price Monitoring System — a claims intelligence capability designed to extend across markets where Carrot processes fertility, family-building, and maternity claims worldwide.
The system is the second AI capability Carrot has introduced, following the company's recent presentation of Sprints, the first AI and wearable-driven metabolic-fertility program, at the National Conference on Women's Health hosted by the U.S. Department of Health and Human Services.
A global market growing faster than its guardrails
New fertility clinics, surrogacy agencies, donor banks, and adoption attorneys are emerging rapidly across every region, many in countries with limited or no consumer protection infrastructure. Employees increasingly travel internationally for treatment, creating pricing opacity: the same IVF cycle can cost dramatically different amounts depending on the country, the provider, and whether a third-party payer is involved.
The financial exposure is real. Surrogacy agencies have been found mismanaging funds and overcharging intended parents in countries with limited regulatory frameworks. Multiple nations have halted or suspended international adoption programs after government investigations uncovered systemic billing fraud and abuse. And fertility clinics routinely charge dramatically different prices for the same procedures depending on whether a third-party payer is involved — with no standardized system to flag the discrepancy.
These are not edge cases. They are symptoms of a structural problem: employer dollars are flowing into a global care market that lacks the intelligence to protect them.






